Evaluation of materials for use in extracorporeal circulation. In vitro serum-material interaction. 1991

K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
Department of Biomedical Engineering and Applied Therapeutics, Cleveland Clinic Foundation, Ohio.

Polymeric membranes used in extracorporeal circulation procedures of varying hydroxyl (-OH) percent were evaluated with normal human serum to detect differences between chemical composition and serum-material interactions. The materials were evaluated as hollow fibers built into modules, including polypropylene (PP; 0%), polyvinyl alcohol (PVA; 23.7%), ethylene vinyl alcohol (EVAL; 29.7%), Cuprophan (CP; 31.5%), and Hemophan (HP; 30.9%). Data from serum perfusions expressed as percent changes to sham (circuit minus module) showed that solute % decreases were from 0% to 10% in all materials except for PVA (10-22%). Complement activation product % increases were higher with PVA (606-4309%) and CP (48-567%), and mononuclear cell transformation functions (MNCTFs) were more suppressed with PVA (100 to 98%) and CP (10-18%). Despite EVAL and HP having an -OH %, complement activation products were relatively low with EVAL (less than 212%), HP (less than 13%), and PP (less than 131%). MNCTFs were stimulatory with the co-polymer of vinyl alcohol and ethylene (EVAL), and very suppressed by serums from PVA contact. Ethylene vinyl alcohol and modified cellulose (HP) had reduced complement activation despite higher or comparable bulk -OH. Bulk -OH content alone cannot explain the differences observed.

UI MeSH Term Description Entries
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D005112 Extracorporeal Circulation Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation. Circulation, Extracorporeal,Circulations, Extracorporeal,Extracorporeal Circulations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006878 Hydroxides Inorganic compounds that contain the OH- group.
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D017665 Hydroxyl Radical The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.

Related Publications

K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
January 1987, Life support systems : the journal of the European Society for Artificial Organs,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
January 1987, Life support systems : the journal of the European Society for Artificial Organs,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
March 2002, Perfusion,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
January 1999, Perfusion,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
January 1967, Grudnaia khirurgiia (Moscow, Russia),
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
January 1998, ASAIO journal (American Society for Artificial Internal Organs : 1992),
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
November 1959, Journal of applied physiology,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
November 1985, The International journal of artificial organs,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
January 1972, International anesthesiology clinics,
K Sawada, and P S Malchesky, and T Ohshima, and J B Goldcamp, and J M Guidubaldi, and S Omokawa
July 1968, Revista brasileira de medicina,
Copied contents to your clipboard!